Literature DB >> 16651010

Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses.

Jeffrey S Spence1, Patrick S Carmack, Richard F Gunst, William R Schucany, Wayne A Woodward, Robert W Haley.   

Abstract

Proportional scaling models are often used in functional imaging studies to remove confounding of local signals by global effects. It is generally assumed that global effects are uncorrelated with experimental conditions. However, when the global effect is estimated by the global signal, defined as the intracerebral average, incorrect inference may result from the dependency of the global signal on preexisting conditions or experimental manipulations. In this paper, we propose a simple alternative method of estimating the global effect to be used in a proportional scaling model. Specifically, by defining the global signal with reference strictly to a white matter region within the centrum semiovale, the dependency is removed in experiments where white matter is unaffected by the disease effect or experimental treatments. The increase in the ability to detect changes in regional blood flow is demonstrated in a SPECT study of healthy and ill Gulf War veterans in whom it is suspected that brain abnormalities influence the traditional calculation of the global signal. Controlling for the global effect, ill veterans have significantly lower intracerebral averages than healthy controls (P = 0.0038), evidence that choice of global signal has an impact on inference. Scaling by the modified global signal proposed here results in an increase in sensitivity leading to the identification of several regions in the insula and frontal cortex where ill veterans have significantly lower SPECT emissions. Scaling by the traditional global signal results in the loss of sensitivity to detect these regional differences. Advantages of this alternative method are its computational simplicity and its ability to be easily integrated into existing analysis frameworks such as SPM.

Entities:  

Mesh:

Year:  2006        PMID: 16651010     DOI: 10.1016/j.neuroimage.2006.03.025

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  6 in total

1.  A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.

Authors:  Pasquale Anthony Della Rosa; Chiara Cerami; Francesca Gallivanone; Annapaola Prestia; Anna Caroli; Isabella Castiglioni; Maria Carla Gilardi; Giovanni Frisoni; Karl Friston; John Ashburner; Daniela Perani
Journal:  Neuroinformatics       Date:  2014-10

2.  Cerebral blood flow abnormalities in patients with neurally mediated syncope.

Authors:  Eun Yeon Joo; Seung Bong Hong; Minjoo Lee; Woo Suk Tae; James Lee; Suk Won Han; Ki-Hwan Ji; Minah Suh
Journal:  J Neurol       Date:  2010-10-01       Impact factor: 4.849

3.  Effect of modafinil on cerebral blood flow in narcolepsy patients.

Authors:  Eun Yeon Joo; Dae Won Seo; Woo Suk Tae; Seung Bong Hong
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

4.  Reduced cerebral blood flow during wakefulness in obstructive sleep apnea-hypopnea syndrome.

Authors:  Eun Yeon Joo; Woo Suk Tae; Sun Jung Han; Jae-Wook Cho; Seung Bong Hong
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

5.  Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.

Authors:  Chiara Cerami; Pasquale Anthony Della Rosa; Giuseppe Magnani; Roberto Santangelo; Alessandra Marcone; Stefano F Cappa; Daniela Perani
Journal:  Neuroimage Clin       Date:  2014-12-05       Impact factor: 4.881

6.  Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.

Authors:  Daniela Perani; Pasquale Anthony Della Rosa; Chiara Cerami; Francesca Gallivanone; Federico Fallanca; Emilia Giovanna Vanoli; Andrea Panzacchi; Flavio Nobili; Sabina Pappatà; Alessandra Marcone; Valentina Garibotto; Isabella Castiglioni; Giuseppe Magnani; Stefano F Cappa; Luigi Gianolli
Journal:  Neuroimage Clin       Date:  2014-10-24       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.